Primary transcriptomes of Mycobacterium avium subsp. paratuberculosis reveal proprietary pathways in tissue and macrophages
- Harish K Janagama†1,
- Elise A Lamont†1,
- Sajan George1,
- John P Bannantine4,
- Wayne W Xu3,
- Zheng J Tu3,
- Scott J Wells1,
- Jeremy Schefers1 and
- Srinand Sreevatsan1, 2Email author
© Janagama et al; licensee BioMed Central Ltd. 2010
Received: 7 May 2010
Accepted: 12 October 2010
Published: 12 October 2010
Mycobacterium avium subsp. paratuberculosis (MAP) persistently infects intestines and mesenteric lymph nodes leading to a prolonged subclinical disease. The MAP genome sequence was published in 2005, yet its transcriptional organization in natural infection is unknown. While prior research analyzed regulated gene sets utilizing defined, in vitro stress related or advanced surgical methods with various animal species, we investigated the intracellular lifestyle of MAP in the intestines and lymph nodes to understand the MAP pathways that function to govern this persistence.
Our transcriptional analysis shows that 21%, 8% and 3% of the entire MAP genome was represented either inside tissues, macrophages or both, respectively. Transcripts belonging to latency and cell envelope biogenesis were upregulated in the intestinal tissues whereas those belonging to intracellular trafficking and secretion were upregulated inside the macrophages. Transcriptomes of natural infection and in vitro macrophage infection shared genes involved in transcription and inorganic ion transport and metabolism. MAP specific genes within large sequence polymorphisms of ancestral M. avium complex were downregulated exclusively in natural infection.
We have unveiled common and unique MAP pathways associated with persistence, cell wall biogenesis and virulence in naturally infected cow intestines, lymph nodes and in vitro infected macrophages. This dichotomy also suggests that in vitro macrophage models may be insufficient in providing accurate information on the events that transpire during natural infection. This is the first report to examine the primary transcriptome of MAP at the local infection site (i.e. intestinal tissue). Regulatory pathways that govern the lifecycle of MAP appear to be specified by tissue and cell type. While tissues show a "shut-down" of major MAP metabolic genes, infected macrophages upregulate several MAP specific genes along with a putative pathogenicity island responsible for iron acquisition. Many of these regulatory pathways rely on the advanced interplay of host and pathogen and in order to decipher their message, an interactome must be established using a systems biology approach. Identified MAP pathways place current research into direct alignment in meeting the future challenge of creating a MAP-host interactome.
Mycobacterium avium subsp. paratuberculosis (MAP) causes one of the most well documented chronic diseases of ruminants worldwide (Johne's disease (JD)) and yet the cues leading to its intracellular survival live in obscurity. Major hindrances involved in examining gene regulation during MAP infection are the low amounts of bacterial RNA isolated from an infected host and the lack of an appropriate animal model . In order to overcome the limited quantity of RNA, previous transcriptomic studies interrogating genes used in pathogenic mycobacterial infection were conducted utilizing mimetic conditions of infection in an in vitro environment (i.e. hypoxia, nutrient starvation, acid and nitric oxide (NO) stresses, etc.) [2, 3].
While these studies provided insight into a limited number of genes regulated by specific cues, it is not representative of natural infection since mycobacteria will encounter more than one stress at a time. Multiple stressors may change which genes are utilized as well as potential for gene:gene or protein:protein interactions that influence survival and dissemination in the host. Therefore, current investigations into the intracellular fate of MAP and host responses rely on in vitro macrophage models, specifically bovine and murine cells[3–8]. Studies from our laboratory using an in vitro bovine macrophage infection model in conjugation with selective capture of transcribed sequences (SCOTS) revealed upregulation of MAP genes involved in combating oxidative stress, metabolic and nutritional starvation and cell survival at 48 and 120 hrs post infection. These results indicate that common sets of genes are required for MAP to persist within a multifaceted host environment. Furthermore, consistent with another study using SCOTS analysis with Mycobacterium avium, MAP expresses several genes involved in fatty acid degradation, which has been suggested as a universal theme used by pathogenic mycobacteria to successfully efface and invade macrophages and other cell types [10–12].
The utility of results from in vitro macrophage infections, as well as small animal models, is controversial as it is currently unknown if these applications faithfully reflect natural infection in MAP's preferred host. A recent study by Meyer-Barber et al. shows discrepant requirements for Toll expression between isolated murine bone marrow derived macrophages from in vitro and in vivo M. tuberculosis infection. Since pathogens initiate and inhibit host signaling (i.e. recognition or evasion), there is also a potential for MAP regulatory networks to differ during in vivo infection. Additionally, a number of articles investigating host-MAP interactions use BOMAC (bovine macrophage) cells due to the advantage of having a cell line[13, 14]. However, BOMAC cells are inherently dysfunctional; lacking several receptors and possessing an insufficient capability to phagocytose MAP[8, 15]. Therefore, macrophage studies to date may 1) underestimate the speed of MAP responses and/or 2) may be serving as an apparition of rather than being an accurate representation of infection. More importantly, in vitro macrophage studies do not address the initial events that set the venue for MAP's transition into the macrophage. Prior to residing inside gut macrophages, MAP must first encounter the intestinal epithelium . The intestinal epithelium represents a formidable fortress that actively secretes IgA and antimicrobial peptides, which is shielded by the glycocalyx and a thick layer of mucus, produced by intestinal goblet cells . Therefore, it is of little surprise that most of the disease signs associated with JD (i.e. transmural inflammation, corrugation, and gross lesions) are inflicted upon the intestinal tissue. Despite MAP's successful siege against the intestinal barrier as evidence of its infiltration into lamina propria macrophages, the exact genes and pathways MAP employs within the intestinal epithelium remains a black hole in our understanding of overall pathogenesis. Furthermore, it has been suggested that MAP processing by the epithelium may aid in efficiency of invasion in macrophages by pre-exposure to a hyperosmolar environment or expression of a MAP oxidoreductase (MAP3464) [17, 18]. Thus, it seems short sighted to assume that no disparate mechanisms are used to survive in the intestinal tissue and macrophage given two different cell types with varying function. Furthermore, data compiled by the Immune Epitope Database and Analysis (IEDB) suggest that specific mycobacterial epitopes are present only within a given host. Studies using small animal models, such as the mouse, may not capture a comprehensive MAP epitope profile as well as transcriptome representative of the cow. The elucidation of host-specific epitopes and MAP genes required for survival during natural infection are expected to aid in the rational design of JD vaccines.
The aim of this study was to characterize the functional MAP transcriptional profiles in the ileum and mesenteric lymph node (MLN) of naturally infected cattle as well as an in vitro bovine monocyte derived macrophages (MDMs) infection model. We have employed advanced molecular techniques, computational and bioinformatic analyses to identify and characterize MAP gene expression during the natural infection process.
Isolation and identification of MAP
Fecal culture results of MAP isolated from intestinal tissues
Mesenteric lymp node
Mesenteric lymp node
Gene expression of MAP during natural infection
List of operons expressed in tissues
Cell wall biosynthesis
Fatty acid degradation
Fatty acid biosynthesis
Fatty acid biosynthesis
Gene expression of MAP in an in vitro macrophage infection assay
A total of 562 MAP genes were differentially expressed during macrophage infection compared with broth culture. Amongst them, 556 genes had a ≥1.5 fold change and 462 genes had ≥ 2.0 fold change (p ≤ 0.05). At 6 hr post infection (PI), upregulated genes of significant interest included serine/threonine protein kinase, pkn B (MAP0016c), ATPase, AAA family protein (MAP0167) and PPE family protein (MAP1675). At 48 hour PI MAP upregulated PE family proteins (MAP0140; MAP0339, MAP1507), transcriptional regulators (MAP0475; MAP2428c) and fad D27 protein (MAP3156). Finally, at 120 hr PI MAP displayed higher induction of genes concerning major membrane protein, mmp L4 (MAP0076, MAP1240c), MCE-family proteins (MAP0566, MAP0759), PE-family proteins (MAP0140; MAP4076), oxidoreductase (MAP0444; MAP3507), lipase, lip E (MAP0248) and ABC transporters (MAP0563). A total of 55 genes were shared across different time points in the macrophage infection assay using MAP K-10 strain. Fig. 2 shows the distribution of the differentially expressed genes across three time points and Additional file 1, Tables S4, S5 and S6 shows the detailed list of genes.
Comparisons of gene expression profiles of naturally infected tissues and in vitro macrophage infection
While a total of 126 genes were commonly expressed between infected tissues and macrophages, 928 and 336 genes were specifically represented in tissues or macrophages, respectively (Fig. 2, Additional File 1, Tables S1 and S7). Functional categories belonging to transcription (MAP1631c, MAP1634, MAP3967) and inorganic ion transport and metabolism (MAP1110, MAP3773c, MAP4171) were represented both in tissues and macrophages (Additional Fig. 2). Macrophage specific gene expression represented functional categories belonging to cell cycle control (MAP2990c), cell wall biogenesis (MAP0670c), cell motility (MAP1506) and secretion (MAP1515). Tissue specific gene expression included genes categorized into virulence mechanisms and those that were not represented in any of the COG groups. Furthermore, MAP regulates expression of persistence related genes such as MAP0033c (WhiB family protein), MAP0038 (probable biofilm regulator), and MAP0075 (mycobacterium specific membrane protein) during natural infection.
Expression of MAP lineage specific genes during natural infection
Approximately 96 genes distributed in six loci (LSP 4, 11, 12, 14 and 15) were recently described as MAP lineage specific genomic insertions; majority of these genes were consistently upregulated (fold change > 2.0, p < 0.05) in the in vitro infected macrophages whereas downregulated in the tissues of both the animals (Additional File 1, Tables S8 and S9) . Loci of interest include LSP 4 and 11, which carry putative prophages, transposons and unique sequences with no hits in NCBI. MAP0858, located within LSP 4, has conserved domains resembling those of a virulence factor (proteophosphoglycan) belonging to Leishmania. LSP11 contains MAP2149c, which has conserved domains to that of SARP (S treptomyces A ntibiotic R egulatory P rotein) family transcriptional factor. Located within LSP 12 includes a mammalian cell entry (mce) operon (MAP2190 - MAP2194) which was downregulated in the tissues whereas MAP2189 (mce) and MAP2180c (a beta lactamase like protein) were upregulated in the macrophages. Downregulated genes located within LSP 14 belong to ABC transporter operon (MAP3731c - MAP3736c), siderophore biosynthesis operon (MAP3741 - MAP3746) and oxidoreductase (MAP3756c). However, an oxidoreductase (MAP3744), and ABC type transporter (MAP3739c) and a polyketides synthase (MAP3763c) belonging to LSP14 were all upregulated in macrophage infections. An ABC transporter operon (MAP3774c - MAP3776c), which is located on LSP 15, was downregulated in infected tissues. Interestingly, MAP3773c, a probable Ferric Uptake Regulator protein on LSP 15, was downregulated in the tissues and upregulated in experimentally infected macrophages. Lastly, located within the LSP specific for cattle MAP strains is an enzyme involved in xenobiotic biodegradation and metabolism (MAP1728c yfnB) was downregulated in the tissues whereas upregulated in the in vitro infected macrophages.
Real-time validation of microarray data
The hallmark of MAP infection is the subclinical manifestation of a persistent intestinal infection. Yet, surprisingly, there remains a paucity of studies investigating the intracellular lifestyle of MAP in the intestinal epithelium in comparison to research involving macrophage and/or lymphocyte models [4, 9]. We sought to fill this critical knowledge gap by reporting the first transcriptome analysis of MAP in infected tissues and macrophages. Both the ileum and mesenteric lymph node have been suggested to act as potential MAP reservoirs within the host; therefore, it is critical to understand the MAP pathways that function to govern this persistence [1, 20, 21]. The current trend in MAP research is to isolate and analyze regulated gene sets given defined, in vitro stress related cues or during a particular infection stage using surgical methods and various animal species [3, 22, 23]. However, we have taken a more directed approach to uncover common and unique pathways utilized by MAP in intestinal tissues using the natural host under natural infection. Elucidation of the transcriptome active in local infection sites is expected to not only augment our knowledge of MAP pathogenesis, which will lend itself to the establishment of a host-pathogen interactome, as well as rational design of vaccines and/or antimycobacterial therapeutic modalities.
MAP residing within the ileum is primed for persistence in subclinical infection
Pathogenic mycobacteria have the uncanny ability to persist within the host for an indefinite period of time that can last several years[24, 25]. Although the genes and signals that induce persistence remain unclear, mycobacteria entering this phase are characterized by a state of chronic or prolonged non-replication . One cue that primes the cell to enter into the non-replication stage is the stringent response, which is characterized by the relA controlled production of hyperphosphorylated guanosine ((p)ppGpp) activated upon nutrient deprivation, hypoxia and oxidative stress [26, 27]. Together relA and (p)ppGpp are able to combat hostile environments by negatively regulating bacterial "life" signals such as DNA and protein machinery. Interestingly, we have identified a unifying theme from naturally infected host tissue as the downregulation of several energy, carbohydrate, amino acid and lipid metabolism as well as transcriptional and DNA replication related genes. Similar attributes of the stringent response were found to be selectively upregulated within the ileum. For example, the RelA/SpoT domain-containing protein has a three-fold upregulation in the ileum. Recently Geiger and colleagues have shown that the RelA/SpoT domain-containing protein, RSH synthetase/hydrolase enzyme, in Staphylococcus aureus is responsible for maintained production of (p)ppGpp and concomitant repression of genes regulating translational machinery . Furthermore, a single metabolism gene regulating menaquinone biosynthesis and consequent production of vitamin K (MAP4052) was uniquely upregulated in the ileum. In addition to initiating the synthesis of mycobactins, menaquinone biosynthesis genes have been shown to be a critical factor in maintaining non-replicating mycobacterial cell viability.
Stringent response priming of MAP cells is most likely due to host inflicted stresses, particularly nitric oxide resultant in DNA damage. Previous studies examining MAP "scrapings" from the intestinal wall of JD clinical cattle show significant upregulation of katG, a bacterial catalase gene used to combat oxidative stress. Furthermore, granulomatous lesions within the ileum or lymph node isolated from cattle naturally infected with either MAP or M. bovis, respectively, have enhanced immune-staining for natural resistance-associated macrophage protein 1 (NRAMP1) and inducible nitric oxide synthase (iNOS), which together synthesize nitric oxide [32, 33]. Although we did not identify enrichment of katG in the ileum, we show upregulation of MAP2836, a LexA repressor, which is stimulated upon DNA damage and stress and results in the arrest of cell division and induction of DNA repair. Similarly, increase in a LysR transcriptional regulator (MAP2442) within the ileum is indicative of an oxidative stress response. These data suggest that during the early stages of infection, MAP is primed for persistence by the stringent response in order to avoid oxidative stress and DNA damage. This appears to be a "watershed moment" in the intracellular lifecycle of MAP as persistence during subclinical infection will ensure its survival and future dissemination into other organs.
MAP evades immune detection in the MLN
Similar to MAP pathways found in the ileum, the majority of MAP genes involved in energy, carbohydrate, inorganic ion, DNA repair, transcription and translation pathways are downregulated. However, there is a lack of stringent response as well as persistence-associated expression. The MLN contains populations of circulating effector cells, such as T and B cells; therefore, MAP may downregulate the aforementioned pathways to avoid detection by the host immune system. Furthermore, common to both ileum and MLN, MAP upregulates several genes associated with cell envelope and outer member biogenesis (MAP1905c, MAP3019c and MAP3979). It is well established that mycobacterial cell wall components have immunomodulatory functions that enable pathogenic mycobacteria to escape immune surveillance by suppression of pro-inflammatory cytokines, phagosome-lysosome fusion and MHC class II presentation[5, 36–38]. Thus, MAP may surround itself with complex cell wall associated glycolipids to prevent recognition and continue t unabated by the host immune system.
Expression of lineage specific large sequence polymorphisms (LSPs) during natural and in vitro macrophage infection
Comparative genomics of the M. avium complex (MAC) revealed that MAP evolved as a pathogen by acquiring large segments of DNA (i.e. pathogenicity islands) via horizontal gene transfer [19, 39–41]. Our study is the first to directly show that some of these putative pathogenicity islands are associated with virulence. Contrary to expression found within the tissues, genes belonging to the LSPs were upregulated in macrophage infection. Qt-RT-PCR analysis also demonstrated that MAP1728c (yfnB), a gene involved in xenobiotic biodegradation and metabolism located within the LSP (deletion 2) specific for cattle MAP strains was downregulated in the tissues . This is consistent with the regulation of other MAP genes, which suggests that MAP transcriptional machinery remains silent in the tissues. Several iron related genes were downregulated in tissues including LSP15, a MAP unique pathogenicity island that encodes a ferric uptake regulator (MAP3773c), as well as the ABC transporter (MAP3731c - MAP3736c), and a possible siderophore biosynthesis operon (MAP3741-MAP3746) that contains a FUR binding box within the intergenic region . This is of significant interest as part of this region (MAP3731c-MAP3736c) has previously been shown to be immunogenic and preliminary studies indicate its use as a potential vaccine candidate. Furthermore, our genome analysis revealed that a type VII secretory system (esx3) was located immediately downstream of LSP15. Esx3 has recently been shown to be essential for mycobactin synthesis and we have identified its repression by the MAP iron dependent regulator (IdeR) in the presence of iron [44, 45]. Taken together, transcriptional analysis suggests that LSP14, 15 and esx-3 form a major pathogenicity island that may play a potential role in maintaining iron homeostasis and hence survival within the macrophage.
MAP is an extremely resilient pathogen that employs a number of regulatory pathways to ensure its survival. Regulatory pathways that govern the lifecycle of MAP appear to be specified by tissue and cell type. While tissues show a "shut-down" of major MAP metabolic genes, infected macrophages upregulate several MAP specific genes along with a putative pathogenicity island responsible for iron acquisition. Despite differences in gene programs found within tissues and cell types, the overriding rule of MAP is to progress by deception either by entering a persistent state, shielding by complex cell wall components or hiding in the macrophage. Many of these programs rely on the advanced interplay of host and pathogen and in order to decipher their message, an interactome must be established using a systems biology approach [25, 46]. Preliminary interactomes for the current study are reminiscent of those being developed for S. pyogenes and H. pylori and show promising networks that may aid in our understanding of overall pathogenesis as well as potential targets for novel vaccines and therapeutics [47, 48]. The findings presented in this study will lend themselves in meeting this future challenge of creating a MAP-host interactome.
All cattle work in this study was performed according to institutional guidelines and approved animal care and use protocols at the University of Minnesota.
Sampling from subclinical JD cows
Two sub-clinically infected but apparently healthy dairy cattle, identified as low shedders by routine serological and fecal culture methods at the University of Minnesota Veterinary Diagnostic Laboratory, were purchased from a farmer and euthanized for this study. The infection status of the animals were established using standard serology for MAP-specific antibody (Idexx Laboratories, Inc., Westbrook, ME)  and fecal culture. At necropsy, sections from affected portions of the intestines ileum, ileocecal junctions, and the surrounding enlarged mesenteric lymph nodes (MLN) were harvested, wrapped in aluminum foil and either snap-frozen in liquid nitrogen or fixed in formalin for RNA extraction and histopathological examination, respectively. All samples were stored at -80.0°C until RNA extraction. Furthermore organs were triturated and cultured for of the presence MAP using standard mycobacterial culture techniques. Sections of the MLN and ileum were taken for microscopy using hematoxylin and eosin staining and acid fast staining. A total of seven slides were created and imaged for each stain.
Genotyping of MAP
MAP colonies were sub-cultured in Middlebrook 7H9 broth (MB7H9) (DIFCO, Lawrence, KS) supplemented with oleic acid-albumin-dextrose-catalase (OADC) enrichment medium (Fischer Scientific, Inc., Pittsburgh, PA) and mycobactin J (2 mg/L) (Allied Monitor, Inc., Fayette, Missouri) at 37°C with subtle shaking. MAP isolates were determined free of contaminant bacteria by absence of growth on Brain-Heart Infusion (BHI) agar at 37°C. Following genomic DNA extraction using a standardized protocol (Qiagen, Valencia, CA), isolates were confirmed for MAP specific IS900 insertion sequence by PCR and agarose gel electrophoresis. MAP isolates from infected tissues as well as MAP cattle strain K-10 (MAP K-10) were genotyped based on short sequence repeats (SSR) from two polymorphic (G and GGT) loci as described [48, 49].
Macrophage infection assay
Monocyte derived macrophages (MDMs) were prepared using a previously described method [4, 51]. Briefly, blood was collected from the jugular vein of a JD-free healthy cow and mixed with an equal portion of acid-citrate dextrose to prevent coagulation. Blood was transferred in 40 mL aliquots into DNase/RNAse free conical tubes and centrifuged at 2,200 rpm for 20 min. at room temperature. Buffy coats were separated, washed in 1X D-PBS and layered on a 58% percoll gradient (Sigma-Aldrich, St. Louis, MO). Cells were collected from percoll, washed 1X PBS and expanded in RPMI containing 20 percent autologous serum at 37°C in 5 percent CO2. MDMs were allowed to incubate for 4 days prior to seeding. MDMs were subsequently seeded at ~2.0 × 107 cells/flask in 25 cm2 flasks and allowed to adhere for 2 hr. A seed stock of MAP K-10 was sub-cultured and grown to mid-logarithmic growth phase (OD600 = 1.0) in MB7H9 broth (supplemented with OADC enrichment medium and 2 μg/ml of mycobactin J) at 37°C on a shaker set at 120 rpm. MAP K-10 was used at a 20:1 multiplicity of infection (MOI) in all infections. Infection was conducted in RPMI containing 2% autologous serum. Following infection after 2 hr,, MDMs were washed twice with fresh, pre-warmed serum-free RPMI 1640 (Gibco(r) Invitrogen, Inc., Carlsbad, CA) to remove non-adherent bacteria and the cultures were subsequently grown in RPMI 1640 with 2% autologous serum for 6, 48 and 120 hrs in duplicate at each time point.
Nucleic acid extraction
Prior to RNA extraction, all surfaces and equipment were treated with RNAse Away (Molecular Bioproducts, Inc., San Diego, Inc.). For total RNA extraction, ~30 mg of mesenteric lymph nodes and ileum were ground separately in liquid nitrogen using a mortar and pestle and dissolved in 600 μL of RLT buffer (Qiagen Inc., Valencia, CA). Total RNA from infected MDMs (6, 48 and 120 hrs p.i,) and MAP K-10 broth cultures were extracted by TRIzol reagent (Invitrogen Inc., Carlsbad, CA) per manufacturer's instructions. Samples were homogenized in a mini bead-beater (Biospec) with 0.3 ml of 0.1 mm sterile RNase-free zirconium beads for 4 min. followed by RNA extraction using RNeasy (Mini) kit (Qiagen Inc., Valencia, CA). All samples were treated with RNase-free DNase I (Ambion, Inc., Austin, TX) to eliminate genomic DNA contamination. The purity and yield of total RNA samples was examined using Nanodrop spectrophotometer (Thermo Scientific Inc., Wilmington, DE) and Agilent 2100E Bioanalyzer (Agilent Technologies, Inc., Santa Clara, CA). Purity of RNA samples were validated by the absence of MAP locus 251 amplification via PCR. All samples were stored at -80°C until later analysis.
Enrichment and confirmation of MAP transcripts
Total RNA obtained from naturally infected tissues and experimentally infected MDMs were processed to remove host RNA as well as ribosomal RNA. Similarly, the total RNA from broth cultures of tissue isolates and MAP K-10 were enriched for bacterial messenger RNA by removing ribosomal RNA. All samples were subjected to RNA amplification and analyzed on a regular denaturing agarose gel and Agilent 2100 bioanalyzer (Agilent Technologies, Santa Clara, CA). Furthermore, the presence of MAP specific genes was confirmed using RT-PCR, sequencing and BLAST analyses (data not shown) prior to use in microarrays.
Sample processing and microarray hybridizations
All microarray experiments were conducted using the minimal information about a microarray experiment (MIAME) guidelines. Polyadenylated host mRNA and bacterial rRNA were eliminated by processing the samples with MICROBEnrich and MICROBExpress Bacterial mRNA Purification Kits (Ambion Inc., Austin, TX), respectively. RNA samples were amplified using MessageAmp(tm) II-Bacteria Kit for prokaryotic RNA amplification system (Ambion Inc., Austin, TX) and labeled with SuperScript(tm) Plus Direct cDNA Labeling System (Invitrogen Inc., Carlsbad, CA). MAP transcripts from infected tissues (two sections each for ileum and mesenteric lymph node) and macrophage infection assay (performed in duplicates) were combined individually with sheared genomic DNA of MAP K-10 labeled with BioPrime(r) Plus Array CGH Genomic Labeling System (Invitrogen Inc., Carlsbad, CA) and hybridized onto 70-mer oligonucleotide microarrays (obtained from Dr. Michael Paustian, NADC, Iowa). Every predicted open reading frame in the MAP strain K-10 genome is represented on this array. One 70-mer was designed for each gene with a total length of less than 4000 bp, while longer genes were split in half and one 70-mer oligo was designed for each half. Additional details of this microarray design can be found elsewhere. RNA from MAP K-10 broth culture and tissue isolates was also processed in the same manner. After overnight hybridization, microarray slides were washed and scanned using the HP Scanarray 5000 (PerkinElmer Inc., Waltham, MA). Images were collected and stored for expression analyses. Microarray experiments were repeated twice for each sample.
Microarray data analysis
Numeric data was extracted from the two-channel hybridization images using the microarray image analysis software, BlueFuse (BlueGnome Ltd, Cambridge). Following normalization by global lowess, the gene expression data was analyzed by GeneSpring GX 10.0 (Agilent Technologies Inc., Foster city, CA). Two group T test was performed to identify the differentially expressed MAP genes (DEGs) and multiple test correction was applied to the T test. The DEGs in natural infected tissues (ileum and mesenteric lymph nodes) and in vitro infected macrophages were identified after normalizing the data with MAP in broth culture. The lists of genes obtained from the above were analyzed using Basic Local Alignment Search Tool (BLAST) algorithm in National Center for Biotechnology Information (NCBI) database against the MAP K-10 genome and the 11 mycobacterial genomes listed in the NCBI databank. Gene IDs were categorized into various functional groups based on Clusters of Orthologous Groups (COGs). Differentially regulated genes were also uploaded in Pathway Studio 6.0 (Ariadne genomics Inc., Rockville, MD) with the M. tuberculosis H37Rv database to explore the cellular context of differentially expressed genes by computational methods of protein network identification.
Quantitative Real-time PCR validation
Primer sequences used in Q-RT PCR
Gene and direction
We would like to thank the Microbial and Plant Genomics Institute, biomedical genomics Center and Computational genetics Laboratory at the University of Minnesota for providing resources and services to perform the studies.
- Hines ME, Kreeger JM, Herron AJ: Mycobacterial infections of animals: pathology and pathogenesis. Lab Anim Sci. 1995, 45 (4): 334-351.PubMedGoogle Scholar
- Schnappinger D, Schoolnik GK, Ehrt S: Expression profiling of host pathogen interactions: how Mycobacterium tuberculosis and the macrophage adapt to one another. Microbes Infect. 2006, 8 (4): 1132-1140. 10.1016/j.micinf.2005.10.027.PubMedView ArticleGoogle Scholar
- Wu CW, Schmoller SK, Shin SJ, Talaat AM: Defining the stressome of Mycobacterium avium subsp. paratuberculosis in vitro and in naturally infected cows. J Bacteriol. 2007, 189 (21): 7877-7886. 10.1128/JB.00780-07.PubMed CentralPubMedView ArticleGoogle Scholar
- Janagama HK, Jeong K, Kapur V, Coussens P, Sreevatsan S: Cytokine responses of bovine macrophages to diverse clinical Mycobacterium avium subspecies paratuberculosis strains. BMC Microbiol. 2006, 6: 10-10.1186/1471-2180-6-10.PubMed CentralPubMedView ArticleGoogle Scholar
- Weiss DJ, Evanson OA, McClenahan DJ, Abrahamsen MS, Walcheck BK: Regulation of expression of major histocompatibility antigens by bovine macrophages infected with Mycobacterium avium subsp. paratuberculosis or Mycobacterium avium subsp. avium. Infect Immun. 2001, 69 (2): 1002-1008. 10.1128/IAI.69.2.1002-1008.2001.PubMed CentralPubMedView ArticleGoogle Scholar
- Motiwala AS, Janagama HK, Paustian ML, Zhu X, Bannantine JP, Kapur V, Sreevatsan S: Comparative transcriptional analysis of human macrophages exposed to animal and human isolates of Mycobacterium avium subspecies paratuberculosis with diverse genotypes. Infect Immun. 2006, 74 (11): 6046-6056. 10.1128/IAI.00326-06.PubMed CentralPubMedView ArticleGoogle Scholar
- Woo SR, Heintz JA, Albrecht R, Barletta RG, Czuprynski CJ: Life and death in bovine monocytes: The fate of Mycobacterium avium subsp. paratuberculosis. Microb Pathog. 2007, 43 (2-3): 106-113. 10.1016/j.micpath.2007.04.004.PubMedView ArticleGoogle Scholar
- Woo SR, Sotos J, Hart AP, Barletta RG, Czuprynski CJ: Bovine monocytes and a macrophage cell line differ in their ability to phagocytose and support the intracellular survival of Mycobacterium avium subsp. paratuberculosis. Vet Immunol Immunopathol. 2006, 110 (1-2): 109-120. 10.1016/j.vetimm.2005.09.010.PubMedView ArticleGoogle Scholar
- Zhu X, Tu ZJ, Coussens PM, Kapur V, Janagama H, Naser S, Sreevatsan S: Transcriptional analysis of diverse strains Mycobacterium avium subspecies paratuberculosis in primary bovine monocyte derived macrophages. Microbes Infect. 2008Google Scholar
- Mayer-Barber KD, Barber DL, Shenderov K, White SD, Wilson MS, Cheever A, Kugler D, Hieny S, Caspar P, Nunez G: Caspase-1 independent IL-1beta production is critical for host resistance to mycobacterium tuberculosis and does not require TLR signaling in vivo. J Immunol. 184 (7): 3326-3330. 10.4049/jimmunol.0904189.Google Scholar
- Hou JY, Graham JE, Clark-Curtiss JE: Mycobacterium avium genes expressed during growth in human macrophages detected by selective capture of transcribed sequences (SCOTS). Infect Immun. 2002, 70 (7): 3714-3726. 10.1128/IAI.70.7.3714-3726.2002.PubMed CentralPubMedView ArticleGoogle Scholar
- Miltner E, Daroogheh K, Mehta PK, Cirillo SL, Cirillo JD, Bermudez LE: Identification of Mycobacterium avium genes that affect invasion of the intestinal epithelium. Infect Immun. 2005, 73 (7): 4214-4221. 10.1128/IAI.73.7.4214-4221.2005.PubMed CentralPubMedView ArticleGoogle Scholar
- Souza CD, Evanson OA, Sreevatsan S, Weiss DJ: Cell membrane receptors on bovine mononuclear phagocytes involved in phagocytosis of Mycobacterium avium subsp paratuberculosis. Am J Vet Res. 2007, 68 (9): 975-980. 10.2460/ajvr.68.9.975.PubMedView ArticleGoogle Scholar
- Langelaar MF, Hope JC, Rutten VP, Noordhuizen JP, van Eden W, Koets AP: Mycobacterium avium ssp. paratuberculosis recombinant heat shock protein 70 interaction with different bovine antigen-presenting cells. Scand J Immunol. 2005, 61 (3): 242-250. 10.1111/j.1365-3083.2005.01559.x.PubMedView ArticleGoogle Scholar
- Tooker BC, Coussens PM: Phagocytosis of M. paratuberculosis fails to activate expression of NADH dehydrogenase and nucleolin-related protein in bovine macrophages. Immunol Lett. 2004, 93 (2-3): 137-142. 10.1016/j.imlet.2004.03.005.PubMedView ArticleGoogle Scholar
- Brandtzaeg P: Mucosal immunity: induction, dissemination, and effector functions. Scand J Immunol. 2009, 70 (6): 505-515. 10.1111/j.1365-3083.2009.02319.x.PubMedView ArticleGoogle Scholar
- Alonso-Hearn M, Patel D, Danelishvili L, Meunier-Goddik L, Bermudez LE: The Mycobacterium avium subsp. paratuberculosis MAP3464 gene encodes an oxidoreductase involved in invasion of bovine epithelial cells through the activation of host cell Cdc42. Infect Immun. 2008, 76 (1): 170-178. 10.1128/IAI.01913-06.PubMed CentralPubMedView ArticleGoogle Scholar
- Patel D, Danelishvili L, Yamazaki Y, Alonso M, Paustian ML, Bannantine JP, Meunier-Goddik L, Bermudez LE: The ability of Mycobacterium avium subsp. paratuberculosis to enter bovine epithelial cells is influenced by preexposure to a hyperosmolar environment and intracellular passage in bovine mammary epithelial cells. Infect Immun. 2006, 74 (5): 2849-2855. 10.1128/IAI.74.5.2849-2855.2006.PubMed CentralPubMedView ArticleGoogle Scholar
- Alexander DC, Turenne CY, Behr MA: Insertion and deletion events that define the pathogen Mycobacterium avium subsp. paratuberculosis. J Bacteriol. 2009, 191 (3): 1018-1025. 10.1128/JB.01340-08.PubMed CentralPubMedView ArticleGoogle Scholar
- Wu CW, Livesey M, Schmoller SK, Manning EJ, Steinberg H, Davis WC, Hamilton MJ, Talaat AM: Invasion and persistence of Mycobacterium avium subsp. paratuberculosis during early stages of Johne's disease in calves. Infect Immun. 2007, 75 (5): 2110-2119. 10.1128/IAI.01739-06.PubMed CentralPubMedView ArticleGoogle Scholar
- Coussens PM: Model for immune responses to Mycobacterium avium subspecies paratuberculosis in cattle. Infect Immun. 2004, 72 (6): 3089-3096. 10.1128/IAI.72.6.3089-3096.2004.PubMed CentralPubMedView ArticleGoogle Scholar
- Allen AJ, Park KT, Barrington GM, Lahmers KK, Hamilton MJ, Davis WC: Development of a bovine ileal cannulation model to study the immune response and mechanisms of pathogenesis of paratuberculosis. Clin Vaccine Immunol. 2009, 16 (4): 453-463. 10.1128/CVI.00347-08.PubMed CentralPubMedView ArticleGoogle Scholar
- Khare S, Nunes JS, Figueiredo JF, Lawhon SD, Rossetti CA, Gull T, Rice-Ficht AC, Adams LG: Early phase morphological lesions and transcriptional responses of bovine ileum infected with Mycobacterium avium subsp. paratuberculosis. Vet Pathol. 2009, 46 (4): 717-728. 10.1354/vp.08-VP-0187-G-FL.PubMedView ArticleGoogle Scholar
- Zahrt TC: Molecular mechanisms regulating persistent Mycobacterium tuberculosis infection. Microbes Infect. 2003, 5 (2): 159-167. 10.1016/S1286-4579(02)00083-7.PubMedView ArticleGoogle Scholar
- Comas I, Gagneux S: The past and future of tuberculosis research. PLoS Pathog. 2009, 5 (10): e1000600-10.1371/journal.ppat.1000600.PubMed CentralPubMedView ArticleGoogle Scholar
- Braeken K, Moris M, Daniels R, Vanderleyden J, Michiels J: New horizons for (p)ppGpp in bacterial and plant physiology. Trends Microbiol. 2006, 14 (1): 45-54. 10.1016/j.tim.2005.11.006.PubMedView ArticleGoogle Scholar
- Potrykus K, Cashel M: (p)ppGpp: still magical?. Annu Rev Microbiol. 2008, 62: 35-51. 10.1146/annurev.micro.62.081307.162903.PubMedView ArticleGoogle Scholar
- Geiger T, Goerke C, Fritz M, Schafer T, Ohlsen K, Liebeke M, Lalk M, Wolz C: Role of the (p)ppGpp synthase RSH, a RelA/SpoT homolog, in stringent response and virulence of Staphylococcus aureus. Infect Immun.Google Scholar
- Bentley R, Meganathan R: Biosynthesis of vitamin K (menaquinone) in bacteria. Microbiol Rev. 1982, 46 (3): 241-280.PubMed CentralPubMedGoogle Scholar
- Dhiman RK, Mahapatra S, Slayden RA, Boyne ME, Lenaerts A, Hinshaw JC, Angala SK, Chatterjee D, Biswas K, Narayanasamy P: Menaquinone synthesis is critical for maintaining mycobacterial viability during exponential growth and recovery from non-replicating persistence. Mol Microbiol. 2009, 72 (1): 85-97. 10.1111/j.1365-2958.2009.06625.x.PubMedView ArticleGoogle Scholar
- Granger K, Moore RJ, Davies JK, Vaughan JA, Stiles PL, Stewart DJ, Tizard ML: Recovery of Mycobacterium avium subspecies paratuberculosis from the natural host for the extraction and analysis in vivo-derived RNA. J Microbiol Methods. 2004, 57 (2): 241-249. 10.1016/j.mimet.2004.01.010.PubMedView ArticleGoogle Scholar
- Delgado F, Estrada-Chavez C, Romano M, Paolicchi F, Blanco-Viera F, Capellino F, Chavez-Gris G, Pereira-Suarez AL: Expression of NRAMP1 and iNOS in Mycobacterium avium subsp. paratuberculosis naturally infected cattle. Comp Immunol Microbiol Infect Dis. 2009Google Scholar
- Estrada-Chavez C, Pereira-Suarez AL, Meraz MA, Arriaga C, Garcia-Carranca A, Sanchez-Rodriguez C, Mancilla R: High-level expression of NRAMP1 in peripheral blood cells and tuberculous granulomas from Mycobacterium bovis-infected bovines. Infect Immun. 2001, 69 (11): 7165-7168. 10.1128/IAI.69.11.7165-7168.2001.PubMed CentralPubMedView ArticleGoogle Scholar
- Butala M, Zgur-Bertok D, Busby SJ: The bacterial LexA transcriptional repressor. Cell Mol Life Sci. 2009, 66 (1): 82-93. 10.1007/s00018-008-8378-6.PubMedView ArticleGoogle Scholar
- Maddocks SE, Oyston PC: Structure and function of the LysR-type transcriptional regulator (LTTR) family proteins. Microbiology. 2008, 154 (Pt 12): 3609-3623. 10.1099/mic.0.2008/022772-0.PubMedView ArticleGoogle Scholar
- Morris KR, Lutz RD, Bai X, McGibney MT, Cook D, Ordway D, Chan ED: Suppression of IFNgamma+mycobacterial lipoarabinomannan-induced NO by IL-4 is due to decreased IRF-1 expression. Tuberculosis (Edinb). 2009, 89 (4): 294-303. 10.1016/j.tube.2009.03.004.View ArticleGoogle Scholar
- Shabaana AK, Kulangara K, Semac I, Parel Y, Ilangumaran S, Dharmalingam K, Chizzolini C, Hoessli DC: Mycobacterial lipoarabinomannans modulate cytokine production in human T helper cells by interfering with raft/microdomain signalling. Cell Mol Life Sci. 2005, 62 (2): 179-187. 10.1007/s00018-004-4404-5.PubMedView ArticleGoogle Scholar
- Sweet L, Singh PP, Azad AK, Rajaram MV, Schlesinger LS, Schorey JS: Mannose receptor-dependent delay in phagosome maturation by Mycobacterium avium glycopeptidolipids. Infect Immun. 78 (1): 518-526. 10.1128/IAI.00257-09.Google Scholar
- Wu CW, Glasner J, Collins M, Naser S, Talaat AM: Whole-genome plasticity among Mycobacterium avium subspecies: insights from comparative genomic hybridizations. J Bacteriol. 2006, 188 (2): 711-723. 10.1128/JB.188.2.711-723.2006.PubMed CentralPubMedView ArticleGoogle Scholar
- Marri PR, Bannantine JP, Golding GB: Comparative genomics of metabolic pathways in Mycobacterium species: gene duplication, gene decay and lateral gene transfer. FEMS Microbiol Rev. 2006, 30 (6): 906-925. 10.1111/j.1574-6976.2006.00041.x.PubMedView ArticleGoogle Scholar
- Turenne CY, Collins DM, Alexander DC, Behr MA: Mycobacterium avium subsp. paratuberculosis and M. avium subsp. avium are independently evolved pathogenic clones of a much broader group of M. avium organisms. J Bacteriol. 2008, 190 (7): 2479-2487. 10.1128/JB.01691-07.PubMed CentralPubMedView ArticleGoogle Scholar
- Stratmann J, Strommenger B, Goethe R, Dohmann K, Gerlach GF, Stevenson K, Li LL, Zhang Q, Kapur V, Bull TJ: A 38-kilobase pathogenicity island specific for Mycobacterium avium subsp. paratuberculosis encodes cell surface proteins expressed in the host. Infect Immun. 2004, 72 (3): 1265-1274. 10.1128/IAI.72.3.1265-1274.2004.PubMed CentralPubMedView ArticleGoogle Scholar
- Heinzmann J, Wilkens M, Dohmann K, Gerlach GF: Mycobacterium avium subsp. paratuberculosis-specific mpt operon expressed in M. bovis BCG as vaccine candidate. Vet Microbiol. 2008, 130 (3-4): 330-337. 10.1016/j.vetmic.2008.01.014.PubMedView ArticleGoogle Scholar
- Siegrist MS, Unnikrishnan M, McConnell MJ, Borowsky M, Cheng TY, Siddiqi N, Fortune SM, Moody DB, Rubin EJ: Mycobacterial Esx-3 is required for mycobactin-mediated iron acquisition. Proc Natl Acad Sci USA. 2009, 106 (44): 18792-18797. 10.1073/pnas.0900589106.PubMed CentralPubMedView ArticleGoogle Scholar
- Janagama HK, Senthilkumar TM, Bannantine JP, Rodriguez GM, Smith I, Paustian ML, McGarvey JA, Sreevatsan S: Identification and functional characterization of the iron-dependent regulator (IdeR) of Mycobacterium avium subsp. paratuberculosis. Microbiology. 2009, 155 (Pt 11): 3683-3690. 10.1099/mic.0.031948-0.PubMed CentralPubMedView ArticleGoogle Scholar
- Bumann D: System-level analysis of Salmonella metabolism during infection. Curr Opin Microbiol. 2009, 12 (5): 559-567. 10.1016/j.mib.2009.08.004.PubMedView ArticleGoogle Scholar
- Shea PR, Virtaneva K, Kupko JJ, Porcella SF, Barry WT, Wright FA, Kobayashi SD, Carmody A, Ireland RM, Sturdevant DE: Interactome analysis of longitudinal pharyngeal infection of cynomolgus macaques by group A Streptococcus. Proc Natl Acad Sci USA. 107 (10): 4693-4698. 10.1073/pnas.0906384107.Google Scholar
- Sharma CM, Hoffmann S, Darfeuille F, Reignier J, Findeiss S, Sittka A, Chabas S, Reiche K, Hackermuller J, Reinhardt R: The primary transcriptome of the major human pathogen Helicobacter pylori. Nature. 464 (7286): 250-255. 10.1038/nature08756.Google Scholar
- Collins MT: Interpretation of a commercial bovine paratuberculosis enzyme-linked immunosorbent assay by using likelihood ratios. Clin Diagn Lab Immunol. 2002, 9 (6): 1367-1371.PubMed CentralPubMedGoogle Scholar
- Crossley BM, Zagmutt-Vergara FJ, Fyock TL, Whitlock RH, Gardner IA: Fecal shedding of Mycobacterium avium subsp. paratuberculosis by dairy cows. Vet Microbiol. 2005, 107 (3-4): 257-263. 10.1016/j.vetmic.2005.01.017.PubMedView ArticleGoogle Scholar
- Coussens PM, Colvin CJ, Wiersma K, Abouzied A, Sipkovsky S: Gene expression profiling of peripheral blood mononuclear cells from cattle infected with Mycobacterium paratuberculosis. Infect Immun. 2002, 70 (10): 5494-5502. 10.1128/IAI.70.10.5494-5502.2002.PubMed CentralPubMedView ArticleGoogle Scholar
- Paustian ML, Zhu X, Sreevatsan S, Robbe-Austerman S, Kapur V, Bannantine JP: Comparative genomic analysis of Mycobacterium avium subspecies obtained from multiple host species. BMC Genomics. 2008, 9: 135-10.1186/1471-2164-9-135.PubMed CentralPubMedView ArticleGoogle Scholar
- Livak KJ, Schmittgen TD: Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods. 2001, 25 (4): 402-408. 10.1006/meth.2001.1262.PubMedView ArticleGoogle Scholar
This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.